Labcorp Holdings Inc.
LH
NYSE·Healthcare·Medical - Diagnostics & Research·Mkt cap $26.9B
$327.61
▼ -1.52%
P/E
27.05
Mkt Cap
$26.9B
52-Wk Range
$244.52–$341.80
52-Week Range
$244.52 - $341.80
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 19.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Extensive nationwide laboratory network
- Advanced diagnostic technologies
- Comprehensive healthcare testing capabilities
- Strong relationships with healthcare providers and pharmaceutical companies
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Increasing demand for precision medicine
Value
Attractively priced below Medical Devices peer average
Momentum
Hot
+27.1% over 3m
Quality
Stable
Excellent business quality
Dividend
Modest
0.88% yield
Smart-money signal
Who's buying LH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 27, 2026
JUL 30, 2026
Reported EPS of $4.99 vs $4.78 consensus (+4.4% surprise). Revenue of $3.7B vs $3.7B expected (+0.6%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+4.4%
Revenue trend · last 8Q
—
+10%
+5%
+10%
+9%
+6%
+6%
+6%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$3.3B
$3.3B
$3.3B
$3.5B
$3.6B
$3.5B
$3.5B
$3.7B
Margins · last 8Q
Gross
31.8%
Operating
11.9%
Profit
8.0%
Wall Street consensus
3 analysts · 67% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
67%
Hold
33%
Sell
0%
Median Price Target
—
Latest: Deutsche Bank · Jul 31, 2026
vs Industry
How LH stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related